@WolfOfPathogens The Wolf of Pathogens

The Wolf of Pathogens posts on X about $oric, $olma, $dnli, $adpt the most. They currently have [--] followers and [--] posts still getting attention that total [--] engagements in the last [--] hours.

Engagements: [--] #

[--] Week [-----] +758%
[--] Month [-----] +816%

Mentions: [--] #

[--] Week [--] +333%
[--] Month [--] +340%

Followers: [--] #

[--] Week [--] +50%

CreatorRank: undefined #

Social Influence

Social category influence stocks 87.5% cryptocurrencies 70.83% finance 12.5% countries 4.17% celebrities 4.17%

Social topic influence $oric #2, $olma #6, $dnli #3, $adpt #7, $prax #10, $mirm #8, $tara #19, $lona #1, $iobt #7, $apls #2

Top accounts mentioned or mentioned by @paulgathua

Top assets mentioned Oric Pharmaceuticals, Inc. (ORIC) Olema Pharmaceuticals, Inc. (OLMA) Denali Therapeutics Inc. Common Stock (DNLI) Adaptive Biotechnologies Corporation Common Stock (ADPT) Praxis Precision Medicines, Inc. (PRAX) Mirum Pharmaceuticals, Inc. Common Stock (MIRM) Taraxa (TARA) IO Biotech, Inc. (IOBT) Apellis Pharmaceuticals, Inc. Common Stock (APLS) Plug Power, Inc. (PLUG) Abivax SA (ABVX) Ondas Holdings Inc. Common Stock (ONDS) ArbitrageCT (ARCT) Cytokinetics Inc. (CYTK) UnitedHealth Group (UNH) Oscar Health, Inc. (OSCR) Taysha Gene Therapies, Inc. (TSHA) AltLayer (ALT) ImmunityBio, Inc. Common Stock (IBRX) Tyra Biosciences, Inc. (TYRA) Terns Pharmaceuticals, Inc. (TERN) CG Oncology, Inc. (CGON) Xenon Pharmaceuticals Inc (XENE) Athira Pharma, Inc. (ATHA) Arcutis Biotherapeutics, Inc. (ARQT) Prime Medicine, Inc. (PRME) C4 Therapeutics, Inc (CCCC) Black Diamond Therapeutics Inc. (BDTX) Arcus Biosciences, Inc. (RCUS) Iovance Biotherapeutics, Inc. Common Stock (IOVA) Viridian Therapeutics, Inc. Common Stock (VRDN) 4D Molecular Therapeutics Inc. (FDMT) Design Therapeutics, Inc. (DSGN) Alumis Inc. (ALMS) BioMarin Pharmaceutical, Inc. (BMRN) BEAM (BEAM) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Vertex Protocol (VRTX) Candel Therapeutics, Inc. (CADL) Keros Therapeutics, Inc. (KROS) AB (prev. Newton) (AB)

Top Social Posts

Top posts by engagements in the last [--] hours

"$BTAI $TNXP $SLS $TLSA $VRDN $TSHA $ARAV $FDMT $DSGN 87% inst ownership $41m mkt cap with $90m cash and new drug Lasofoxifene Fulvestrant who sold $1.2b last year"
X Link 2026-02-10T18:46Z [--] followers, [---] engagements

"$alt $IBRX $MCRB $TSHA $TYRA $TERN $EYPT $cgon $alt $ibrx $tyra $xene $tern $krus $eypt $olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs $lona lona 87% instit ownership/ Perceptive Tang capital $6.35m insider buy at $6.00 New phase [--] oncology asset"
X Link 2026-02-12T19:21Z [--] followers, [---] engagements

"$ATHA INITIATING: $ATHA at $200 price target (5-year) conservative(66X from current levels). This could be one of the most asymmetric setups in biotech right now. Here's the full thesis 👇"
X Link 2025-12-30T16:34Z [--] followers, [---] engagements

"$olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs massive valuation gap is hiding in plain sight: 🧪 The Drug: Lasofoxifene Fulvestrant ($1.2B sales last year) in ESR1 mutations. 95% Institutional ownership"
X Link 2026-01-27T17:15Z [--] followers, [---] engagements

"$alt $IBRX $MCRB $TSHA $TYRA $TERN $EYPT $cgon $alt $ibrx $tyra $xene $tern $krus $eypt $olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs $lona Lona $6.35m insider open mkt buy $44m mkt cap with $90m cash and new drug Lasofoxifene Fulvestrant who sold $1.2b last year https://twitter.com/i/web/status/2020897117360021931 https://twitter.com/i/web/status/2020897117360021931"
X Link 2026-02-09T16:26Z [--] followers, [---] engagements

"$alt $IBRX $MCRB $TSHA $TYRA $TERN $EYPT $cgon $alt $ibrx $tyra $xene $tern $krus $eypt $olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs $lona lona one of the most mis-priced stocks in the mkt trading less than half cash a phase [--] cancer drug $6.35m insider buy and [----] % institutional ownership https://twitter.com/i/web/status/2021251985257689523 https://twitter.com/i/web/status/2021251985257689523"
X Link 2026-02-10T15:56Z [--] followers, [---] engagements

"$olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs lona potential 10X [----] % inst ownership trading at 1/2 cash with phase [--] cancer drug"
X Link 2026-02-10T16:25Z [--] followers, [---] engagements

"$alt $IBRX $MCRB $TSHA $TYRA $TERN $EYPT $cgon $alt $ibrx $tyra $xene $tern $krus $eypt $olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs $lona: Lona Massive reversal signal. Phase [--] oncology asset. $6.35M insider buy (huge conviction). 87.7% institutional ownership. Smart money loading." https://twitter.com/i/web/status/2021597694582546457 https://twitter.com/i/web/status/2021597694582546457"
X Link 2026-02-11T14:50Z [--] followers, [---] engagements

"$olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvsLona Massive reversal signal. Phase [--] oncology asset. $6.35M insider buy (huge conviction). 87.7% institutional ownership. Smart money loading.""
X Link 2026-02-11T14:52Z [--] followers, [---] engagements

"$alt $IBRX $MCRB $TSHA $TYRA $TERN $EYPT $cgon $alt $ibrx $tyra $xene $tern $krus $eypt $olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs $lonamassive valuation gap is hiding in plain sight: 🧪 Lasofoxifene Fulvestrant ($1.2B sales last year) in ESR1 mutations. 87% Institutional ownership https://twitter.com/i/web/status/2021599627288404357 https://twitter.com/i/web/status/2021599627288404357"
X Link 2026-02-11T14:58Z [--] followers, [---] engagements

"$alt $IBRX $MCRB $TSHA $TYRA $TERN $EYPT $cgon $alt $ibrx $tyra $xene $tern $krus $eypt $olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs $lona Lona Lasofoxifene Fulvestrant ($1.2B annual) 87% Instit huge time arbtitrage oppor"
X Link 2026-02-13T15:09Z [--] followers, [---] engagements

"Why avoiding illness starts in [--] hours https://chatgpt.com/s/m_696d3d2bd1cc8191956da7b6b84a90db https://chatgpt.com/s/m_696d3d2bd1cc8191956da7b6b84a90db"
X Link 2026-01-18T20:06Z [--] followers, [--] engagements

"$PRME $CCCC $BDTX $OBIO $ARQT $RCUS $MNPR $KOD $IOVA $olma $tara $oric $dnli $adpt $prax $mirm $ALMS $lona lona heavy insider buying $27m mkt cap with $90m cash and new drug Lasofoxifene Fulvestrant who sold $1.2b last year"
X Link 2026-01-21T18:04Z [--] followers, [---] engagements

"$VRTX $BEAM $DNTH $BMRN $ARQT $CADL $IONS $KROS $ORIC lona heavy insider buying $27m mkt cap with $90m cash and new drug Lasofoxifene Fulvestrant who sold $1.2b last year"
X Link 2026-01-21T18:05Z [--] followers, [--] engagements

"$ab $lona why is Pelosi buying this little biotech. They just licensed as phase [--] breast cancer drug"
X Link 2026-01-26T16:18Z [--] followers, [---] engagements

"During King Leopold II's rule over the Congo Free State (1885-1908) estimates of Congolese deaths vary considerably but there is growing scholarly consensus around approximately [--] million deaths. A good reminder to the white people abused and going extinct story Elon has going🤣 https://twitter.com/i/web/status/2015824366622093787 https://twitter.com/i/web/status/2015824366622093787"
X Link 2026-01-26T16:29Z [--] followers, [--] engagements

"RT @WolfOfPathogens: $PRME $CCCC $BDTX $OBIO $ARQT $RCUS $MNPR $KOD $IOVA https://x.com/WolfOfPathogens/status/2006041088709054766s=20 https://x.com/WolfOfPathogens/status/2006041088709054766s=20"
X Link 2026-01-20T17:57Z [--] followers, [--] engagements

"$alt $IBRX $MCRB $TSHA $TYRA $TERN $EYPT $cgon $alt $ibrx $tyra $xene $tern $krus $eypt $olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs $lona Lona $6.35m insider open mkt buy $54m mkt cap with $90m cash and new drug Lasofoxifene Fulvestrant who sold $1.2b last year https://twitter.com/i/web/status/2015798123075940529 https://twitter.com/i/web/status/2015798123075940529"
X Link 2026-01-26T14:44Z [--] followers, [---] engagements

"$alt $IBRX $MCRB $TSHA $TYRA $TERN $EYPT $cgon $alt $ibrx $tyra $xene $tern $krus $eypt $olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs $lona Lona $6.35m insider open mkt buy $54m mkt cap with $90m cash and new drug Lasofoxifene Fulvestrant who sold $1.2b last year massive valuation gap is hiding in plain sight: 🧪 The Drug: Lasofoxifene Fulvestrant ($1.2B sales last year) in ESR1 mutations. The Cash: $90M on hand (vs. only a $54M Market Cap). 📷 https://twitter.com/i/web/status/2015890456987476361"
X Link 2026-01-26T20:51Z [--] followers, [---] engagements

"$alt $IBRX $MCRB $TSHA $TYRA $TERN $EYPT $cgon $alt $ibrx $tyra $xene $tern $krus $eypt $olma $tara $oric $dnli $iobt $apls $adpt $prax $mirm $abvx $vnda $plug $arct $lona $onds $cytk $klrs $unh $oscr $crvs $lona Lona $6.35m insider open mkt buy $54m mkt cap with $90m cash and new drug Lasofoxifene Fulvestrant who sold $1.2b last year https://twitter.com/i/web/status/2016197992609448002 https://twitter.com/i/web/status/2016197992609448002"
X Link 2026-01-27T17:13Z [--] followers, [---] engagements

"$PRME $CCCC $BDTX $OBIO $ARQT $RCUS $MNPR $KOD $IOVA https://x.com/WolfOfPathogens/status/2006041088709054766s=20 $ATHA INITIATING: $ATHA at $200 price target (5-year) conservative(66X from current levels). This could be one of the most asymmetric setups in biotech right now. Here's the full thesis 👇 https://x.com/WolfOfPathogens/status/2006041088709054766s=20 $ATHA INITIATING: $ATHA at $200 price target (5-year) conservative(66X from current levels). This could be one of the most asymmetric setups in biotech right now. Here's the full thesis 👇"
X Link 2025-12-31T17:24Z [--] followers, [--] engagements

"$ATHA 1/ Assessing ATH-1105 chances in ALS When comparing ATH-1105 to recent high-profile failures like Denalis DNL343 we see a fascinating contrast. Both drugs are CNS-penetrant small molecules designed to stop the TDP-43 "fire" that kills motor neurons but they attempt to do so from completely different angles"
X Link 2026-01-02T16:58Z [--] followers, [--] engagements

"$olma $tara $oric $dnli $adpt $prax $mirm $atha heavy insider buying $27m mkt cap with $90m cash and new drug Lasofoxifene Fulvestrant who sold $1.2b last year"
X Link 2026-01-07T17:07Z [--] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing